INCIDENCE, MITIGATION, AND MANAGEMENT OF NEUROLOGIC ADVERSE EVENTS IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) IN CARTITUDE-2

Autor: Einsele, H, Parekh, S, Madduri, D, Santomasso, B, Pérez-Larraya, JG, Donk, NWV, Arnulf, B, Mateos, M, Braganca, KC, Varsos, H, Carrasco-Alfonso, MJ, Akram, M, Lendvai, N, Jackson, CC, Olyslager, Y, Zudaire, E, Li, C, Geng, D, Jakubowiak, A, Cohen, A
Zdroj: In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S263-S264
Databáze: ScienceDirect